COMPANY
Chimerocyte Inc.
CHIMEROCYTE INC has received NIH funding, most recently in fiscal 2019 for the project “Highly Sensitive Chimerism Testing to Detect Early Leukemia Relapse Post-Allo-Transplantation”. From public records Source · Oct 12, 2026